Exhibit 15.3
Appendix 4E
Preliminary final report for the twelve months to June 30, 2022
Genetic Technologies Limited
ABN 17 009 212 328
1. | Reporting period |
Report for the financial year ended | June 30, 2022 |
Previous corresponding period is the financial year ended | June 30, 2021 |
2. | Results for announcement to the market |
Up/down | % | Amount reported for the year ended June 30, 2022 | |||||||||||||
$ | |||||||||||||||
Revenues from ordinary activities (item 2.1) | Up | 5,536 | % | to | 6,794,816 | ||||||||||
Loss from ordinary activities after tax attributable to members (item 2.2) |
Up* | 0.8 | % |
to | (7,130,998 | ) | |||||||||
Net loss for the period attributable to members (item 2.3) | Up* | 0.8 | % | to | (7,130,998 | ) |
*increase in loss
There are no dividends being proposed or declared for the period (item 2.4 and 2.5)
Commentary related to the above results
Please refer to ‘Item 5.A Operating results’ within the Form 20-F for the year ended June 30, 2022.
3. | Net tangible assets per security |
June 30, 2022 | June 30, 2021 | June 30, 2020 | ||||||||||
Net tangible asset backing per ordinary security (1) | 0.12 cents | 0.24 cents | 0.17 cents |
(1) | Net tangible assets exclude the right-of-use assets under AASB 16 Leases. |
4. | Other documents accompanying this Appendix 4E |
This Appendix 4E should be read in conjunction with the Genetic Technologies Limited annual report on the form 20-F, which includes:
- | Item 18 Financial Statements; and | |
- | Other sections as tabled below. |
This preliminary final report and the associated Directors’ Report are found throughout the various sections of the accompanying Genetic Technologies Limited annual report on the form 20-F.
The following table has been provided to assist readers to locate each section of the Directors’ Report within the accompanying annual report on the form 20-F.
Sections of Directors’ Report | Form 20-F Reference | |
Principal activities | Item 5.A Operating Results
See subheading – “Overview” | |
Review of operations and activities | Item 4.B Business Overview Item 5.A Operating Results | |
Business strategies and prospects for future years | Item 4.B Business Overview | |
Business risks | Item 3.D Risk Factors | |
Significant changes in the state of affairs | Item 5.A Operating Results
See subheading – “Significant changes in the state of affairs” | |
Matters subsequent to the end of the financial year | Item 8.B Significant Changes Item 5.A Operating Results See subheading – “Likely developments and expected results of operations” | |
Likely developments and expected results of operations | Item 5.A Operating Results
See subheading – “Likely developments and expected results of operations” | |
Environmental regulations | Item 5.A Operating Results
See subheading – “Environmental regulations” | |
Dividends | Item 4.B Business Overview See subheading – “Dividends” | |
Information on directors | Item 6.A Directors and Senior Management | |
Remuneration report | The Remuneration report starts at Item 6 and ends after Item 6.B as indicated | |
Indemnification of officers | Item 6.B Compensation
See subheading – “Indemnification and Insurance with respect to Directors” | |
Proceedings on behalf of the group | Item 8.A Consolidated Statements and Other Financial Information
See subheading – “Legal Proceedings” | |
Non-Audit Services | Item 16.C Principal Accountant Fees and Services | |
Auditor’s independence declaration | Exhibit 15.4 Auditor’s Independence Declaration | |
Directors’ Resolution | Item 6.B Compensation
See subheading – “Directors’ Resolution” |
5. | Audited Financial Report 2022 |
This preliminary final report has been based on accounts which have been audited.
A copy of the audited Financial Statements for the year ended June 30, 2022 is included in Item 18 Financial Statements within the Form 20-F.
- End of Appendix 4E -